KIVALITA CONSULTING
Biweekly News about the life science market! 19/01/2021

Record on imports of chemicals
Brazil imported US$ 3.9 billion in chemicals in
November, according to information from the Brazilian Chemical Industry
Association (Abiquim), and the value represents increases of 10.5% compared to
October this year and 10.6% compared to November 2019.
A year after Avon, Natura & Co already has
new big dream: conquering China
Company doubles value after merger with Avon, to
more than R$ 70 billion, and organizes plans to accelerate international
progress
GlaxoSmithKline and Vir Biotechnology announce
study to evaluate early treatment of Covid-19
GlaxoSmithKline (GSK) and Vir Biotechnology have
announced an agreement on the AGILE platform in the UK to assess, in a phase
1b/2a clinical trial, the use of VIR-7832 in patients with Covid-19 with mild
and moderate symptoms.
Butantan will have to submit remaining data to
Anvisa by February 28
The Butantan Institute,
responsible for the production of coronavac vaccine in Brazil, must present, by
February 28, remaining studies requested by the National Health Surveillance
Agency (Anvisa) on the performance of the immunizer.
Lack of raw material for
Coronavac and Oxford vaccine threatens to delay immunization in Brazil
The difficulties in importing doses and insums
to produce vaccines are a major threat to the Brazilian immunization campaign,
which began the day before yesterday in São Paulo. For specialists, there is a
real risk that vaccination against covid-19 will be stopped in a short time due
to a total lack of immunizers.
Sign up for
our Newsletter and be the first to know about the Life Science market!

Endereço
- Rua dos Três Irmãos, 310 - Sala 302 - Vila Progredior
São Paulo - SP
© 2020 Kivalita Consulting | Todos os direitos reservados